BNTC
Benitec Biopharma Inc.
Company Overview
| Mkt Cap | $424.47M | Price | $16.36 |
| Volume | 73.76K | Change | +1.18% |
| P/E Ratio | -19.5 | Open | $16.00 |
| Revenue | -- | Prev Close | $16.17 |
| Net Income | $-21.8M | 52W Range | $9.10 - $17.15 |
| Div Yield | N/A | Target | $24.86 |
| Overall | 61 | Value | 60 |
| Quality | -- | Technical | 63 |
No chart data available
Stock Overview
Updated DailyBenitec Biopharma Inc. (BNTC) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $16.36 with a market capitalization of $424.47 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BNTC with a volume of 74K shares. The stock opened down 1.05% from yesterday's close of $16.17. Current analyst estimates project earnings of $-2.64 per share for this year, with next year targeting $-2.92.
BNTC demonstrates positive technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including NWBO, NYMX, OHCS, OMIC.
Key investment considerations for BNTC include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 52.0%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:32 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTC | $16.36 | +1.2% | 73.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |